LWMNY
GILD icon

Landmark Wealth Management (New York)’s Gilead Sciences GILD Stock Holding History

Landmark Wealth Management (New York)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$839K Buy
+6,018
New +$843K 0.22% 80
2022
Q2 		– Sell
-300
Closed -$300 – 94
2022
Q1 		$300 Buy
+300
New +$19.2K ﹤0.01% 153

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Landmark Wealth Management (New York)'s GILD Position: Q1 2026 in Review

Landmark Wealth Management (New York) opened a new position in Gilead Sciences (GILD) in Q1 2026: 6,018 shares worth $839K. The stake represents 0.22% of the portfolio and ranks #80 among its holdings. This is a return to the name: Landmark Wealth Management (New York) previously reported a position in GILD as recently as Q1 2022.

Landmark Wealth Management (New York) first reported a position in GILD in Q1 2022 and has held it in 2 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Landmark Wealth Management (New York) held 6,018 shares of Gilead Sciences worth $839K as of Q1 2026.
  • Gilead Sciences was a new Landmark Wealth Management (New York) position in Q1 2026.
  • Gilead Sciences made up 0.22% of Landmark Wealth Management (New York)'s portfolio in Q1 2026, its #80 holding.
  • Landmark Wealth Management (New York) first reported a position in Gilead Sciences in Q1 2022 and has held it in 2 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Landmark Wealth Management (New York)'s 13F filing for Q1 2026, filed 29 Apr 2026.